Promisia widens first-half loss as it chases US expansion

Promisia widens first-half loss as it chases US expansion
By Suze Metherell Aug. 29 (BusinessDesk) - Promisia Intergrative, the listed-therapeutic health supplements company, widened its first-half loss as it looks to expand its Arthrem brand into the United States. The shares gained. The Wellington-based company booked a loss $388,000 in the six months ended June 30, from a previous loss of $72,014 for the same period a year earlier, it said in a statement. Sales rose 85 percent to $122,000. The company's Arthrem brand, which makes a herbal-based dietary supplement pill said to maintain long...